JBS (JBS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Net sales reached $21.6 billion in Q1 2026, up 10.7–11% year-over-year, marking a record first quarter and reflecting strong global demand and diversified operations.
Adjusted EBITDA (IFRS) was $1.13 billion (margin 6.7%), with net income reported between $221 million and $500 million; EPS ranged from $0.21 to $0.47.
Profitability was pressured in Beef North America and Pilgrim's Pride due to cattle cycle challenges and weather disruptions, while Seara and JBS Brazil delivered strong results.
Operational focus included cost discipline, efficiency, leveraging technology, and global expansion through new facilities and acquisitions.
Dual listing on NYSE completed, aiming to broaden investor base and enhance capital flexibility.
Financial highlights
Adjusted EBITDA (IFRS) was $1.13 billion (6.7% margin); U.S. GAAP EBITDA ranged from $916 million to $960 million (4.2%–4.3% margin).
Net income ranged from $221 million to $500 million; EPS from $0.21 to $0.47.
Free cash flow was negative, ranging from -$1.5 billion to -$285 million, reflecting higher CapEx and working capital impacts.
CapEx totaled up to $917 million, with a focus on both maintenance and expansion.
ROE ranged from 22% to 24.1%; ROIC from 14.9% to 22.1%.
Outlook and guidance
Management expects continued strong global protein fundamentals, with constrained beef supply and solid poultry demand.
U.S. beef margins are expected to improve sequentially but remain challenged in 2026, potentially 1–1.5 percentage points lower than 2025.
Focus on global diversification, value-added product expansion, and ongoing investments in innovation and modernization.
CapEx for 2026 targeted at $2.4 billion, with $1.3 billion for expansion; management will monitor leverage and adjust if needed.
Latest events from JBS
- Record 2025 revenue and net income, with global expansion offsetting margin pressures.JBS
Q4 202515 May 2026 - Global protein leader with $88.3B revenue, expanding through diversification and strategic investment.JBS
Investor presentation13 May 2026 - Q2 2024 saw record margins, $329M net profit, and strong cash flow, led by poultry and pork.JBS
Q2 20241 Feb 2026 - Record 3Q24: $19.9B revenue, $2.2B EBITDA, $693M profit, leverage at 2.15x.JBS
Q3 202413 Jan 2026 - Record revenue, margin expansion, and lower leverage highlight robust 2024 performance.JBS
Q4 202420 Dec 2025 - Record revenue and net income growth offset margin pressures in US beef and pork.JBS
Q2 202523 Nov 2025 - Record profit and sales, strong poultry and pork margins, and dual listing plans despite beef headwinds.JBS
Q1 202518 Nov 2025 - Record sales rose 13% to $22.6B, but margins and profitability declined in Q3.JBS
Q3 202514 Nov 2025 - Global protein leader with strong brands, margin growth, and dual NYSE/B3 listing for future expansion.JBS
CAGNY 2025 Presentation3 Jul 2025